| Publication date | Communities | Collections | Article title | Author(s) | Journal/Conference |
|---|---|---|---|---|---|
| 28 May 2019 | BMRC | Bioinformatics Institute | Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer | Denis M. Collins, Neil T. Conlon, Srinivasaraghavan Kannan, Chandra S. Verma, Lisa D. Eli, Alshad S. Lalani, John Crown | Cancers |
| 18 Dec 2014 | BMRC | Bioprocessing Technology Institute | Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling | Filip Laco, Joo-Leng Low, Jasmin Seow, Tsung Liang Woo, Qixing Zhong, Jayasree Seayad, Zhenfeng Liu, Heiming Wei, Shaul Reuveny, David A. Elliott, Christina L. L. Chai, Steve K. W. Oh | Journal of Molecular and Cellular Cardiology |